Merrimack Pharmaceuticals Inc

CIK 1274792 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Merrimack Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
May 20, 202415-12G0001193125-24-142837
May 15, 202410-Q0000950170-24-060478
May 10, 20248-K0001193125-24-136237
May 10, 2024250001193125-24-136243
May 9, 2024DEFA14A0001193125-24-134775
May 9, 20248-K0001193125-24-134773
Apr 30, 20248-K0001193125-24-125367
Apr 30, 2024DEFA14A0001193125-24-125372
Apr 1, 2024DEFR14A0001193125-24-083441
Mar 27, 20248-K0001193125-24-078910
Mar 27, 2024DEFA14A0001193125-24-078920
Mar 22, 2024DEFA14A0001193125-24-074722
Mar 21, 2024DEF 14A0001193125-24-073941
Mar 21, 202410-K/A0001193125-24-073929
Mar 7, 20248-K0001193125-24-062260
Mar 7, 2024SC 13G/A0001086364-24-007251
Mar 7, 202410-K0000950170-24-027966
Mar 7, 20244250001193125-24-062268
Mar 5, 2024PRE 14A0001193125-24-059357
Feb 22, 2024SCHEDULE 13G0001758866-24-000002
Feb 14, 2024SC 13G/A0000921895-24-000491
Feb 13, 2024DEFA14A0001193125-24-033779
Feb 13, 20248-K0001193125-24-033761
Jan 31, 2024SC 13G0001086364-24-006061
Jan 25, 2024SC 13D/A0001493152-24-003744